Breo Ellipta inhalation powder contains a mixture of fluticasone and vilanterol. Fluticasone may be a steroid. It prevents the discharge of gear within the body that cause inflammation. Vilanterol may be a medication. It works by quiet muscles within the airways to enhance respiratory.
Breo Ellipta may be a once-daily combination drugs employed in adults with asthma attack or COPD (chronicimpeding respiratory organ disease), to enhance symptoms and forestall spasm or asthma attack attacks.
In folks with COPD, Breo Ellipta is for long treatment. In folks with asthma attack, this drugs is for short-runtreatment till symptoms ar well-controlled with with different medicines.
Vilanterol could increase the chance of death in folks with asthma attack, however the chance in folks with COPD isn’t well-known. speak together with your doctor regarding your individual risks and advantages ofvictimisation this drugs.
Submit your review
Get emergency medical help if you have signs of an allergic reaction to Breo Ellipta: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
wheezing, choking, or other breathing problems after using this medication;
chest pain, shortness of breath, tremors, nervousness;
feeling very weak or tired, nausea and vomiting, feeling like you might pass out;
blurred vision, tunnel vision, eye pain, or seeing halos around lights;
fever, chills, cough with yellow or green mucus;
sores or white patches in your mouth and throat, pain when swallowing;
low potassium - leg cramps, constipation, irregular heartbeats, fluttering in your chest, extreme thirst, increased urination, numbness or tingling, muscle weakness or limp feeling; or
high blood sugar - increased thirst, increased urination, hunger, dry mouth, fruity breath odor, drowsiness, dry skin, blurred vision, weight loss.
Common Breo Ellipta side effects may include:
runny or stuffy nose, sore throat.
Fluticasone 100 mcg-vilanterol 25 mcg (1 inhalation) orally once a day Maximum dose: 1 inhalation in 24 hours Comments: -Breo Ellipta is not indicated for the relief of acute bronchospasm. -Only fluticasone 100 mcg-vilanterol 25 mcg is indicated for the treatment of COPD. -If shortness of breath occurs in the period between doses, use an inhaled, short-acting beta2-agonist for immediate relief. Uses: Long term maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema; to reduce exacerbations in patients with COPD